However, the calculated DNA-MPO-CitH3 NET content in SLE samples consistently showed a significant increase over healthy controls (Figure 2E), and similar significant differences were seen between homozygous risk and non-risk donors (Figure 2F). This evidence concerns the gene MPO and systemic lupus erythematosus.